4.6 Review

Tumor-related Microbiome in the Breast Microenvironment and Breast Cancer

Journal

JOURNAL OF CANCER
Volume 12, Issue 16, Pages 4841-4848

Publisher

IVYSPRING INT PUBL
DOI: 10.7150/jca.58986

Keywords

microbiome; breast cancer; gut microbiota; diversity

Categories

Funding

  1. CSCO Project [Y-2019Genecast-019]
  2. Liaoning Cancer Hospital Yangtse River Scholars Project
  3. Liaoning Cancer Hospital [LD202022]
  4. LiaoNing Revitalization Talents Program [XLYC1907160]
  5. Dalian University of Technology [LD202022]

Ask authors/readers for more resources

Breast cancer remains a major cause of mortality among females globally, with the microbiome in breast tissue and the tumor microenvironment potentially affecting diagnosis, treatment, and therapeutic response. To address challenges in evaluating tumor-related microbiome, sequencing technology upgrades and machine deep learning algorithms may standardize assessment effectively.
Despite the significant progress in diagnosis and treatment over the past years in the understanding of breast cancer pathophysiology, it remains one of the leading causes of mortality worldwide among females. Novel technologies are needed to improve better diagnostic and therapeutic approaches, and to better understand the role of tumor-environment microbiome players involved in the progression of this disease. The gut environment is enriched with over 100 trillion microorganisms, which participate in metabolic diseases, obesity, and inflammation, and influence the response to therapy. In addition to the direct metabolic effects of the gut microbiome, accumulating evidence has revealed that a microbiome also exists in the breast and in breast cancer tissue. This microbiome enriched in the breast environment and the tumor microenvironment may modulate effects potentially associated with carcinogenesis and therapeutic interventions in breast tissue, which to date have not been properly acknowledged. Herein, we review the most recent works associated with the population dynamics of breast microbes and explore the significance of the microbiome on diagnosis, tumor development, response to chemotherapy, endocrine therapy, and immunotherapy. To overcome the low reproducibility of evaluations of tumor-related microbiome, sequencing technical escalation and machine deep learning algorithms may be valid for standardization of assessment for breast-related microbiome and their applications as powerful biomarkers for prognosis and predictive response in the future.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available